Pharmaceutical technology & manufacturing
Precision at the
particle level.
Advanced multiparticulate drug-delivery systems, formulation intermediates and finished oral dosage forms. Developed with scientific rigour. Engineered for scale.Multiparticulate drug-delivery systems, from formulation to supply.
For pharmaceutical partners in India and international markets.
Your starting point
Where would you like to begin?
A direct path to the products, technology or conversation you need.
I know my ingredient
Go straight to the listed portfolio. Search an ingredient or product name.
Explore a technology
Explore pellets, multiparticulate systems, granules and finished oral dosage forms.
See our capabilities 03 / DEVELOPMENTDevelop something together
Start with your intended dosage form, release profile and target market.
Start a conversationThe Jai Lara approach
Advanced drug delivery.
Considered at every stage.
We combine formulation science, process engineering and analytical evaluation to develop robust, reproducible and scalable pharmaceutical solutions.
Meet Jai LaraThe science of multiparticulates
Small units.
Considered design.
Explore four decisions in pellet formulation: core selection, drug loading, functional coating and release testing.
Your formulation brief
Start with your requirements.
Share your active ingredient, target strength, release profile and intended dosage form so our technical team can discuss the next steps.
Discuss your formulationOur expertise
Focused science. Flexible solutions.
Specialist platforms for formulation intermediates and finished oral dosage forms.
- 01
Pharmaceutical pellets
Immediate-, sustained-, delayed- and enteric-release pellets across a broad active range, the core of our multiparticulate expertise.
- 02
MUPS & multiparticulates
Multi-Unit Pellet Systems and blended multiparticulates enabling fixed-dose combinations in a single dosage unit.
- 03
Granules & SUBA granules
Standard and amorphous / enhanced-bioavailability (SUBA-type) granules, including itraconazole formulations.
- 04
Enteric & controlled release
Enteric coating and modified-release architectures engineered for site-specific and time-controlled delivery.
- 05
Finished formulations
Capsules, tablets and sachets, including fixed-dose combinations built from our own multiparticulates.
- 06
Formulation & analytical development
Pre-formulation, excipient selection, analytical evaluation and stability assessment, with scale-up considered from the outset.
Multiparticulate technology
Intermediates.
Ready for the next step.
Defined physical, chemical and functional properties connect formulation intermediates to the intended dosage form. Requirements are agreed for each programme.
Explore dosage-form pathways- Capsule filling
- Particle and formulation properties defined for onward capsule filling.
- Tablet compression
- Compression requirements considered in the intermediate’s physical, chemical and functional profile.
- Blending
- Intermediates prepared for incorporation into blends, to programme-specific requirements.
From concept to commercialisation
A considered path from formulation to scale.
Development, process optimisation and manufacturing aligned around your product requirements.
- 01
Requirement
We scope the active, release profile, target market and documentation needs.
- 02
Formulation development
Pre-formulation and formulation design aligned to the target product profile.
- 03
Analytical development
Method development and validation to support characterisation and release.
- 04
Scale-up
Process transferred from lab to commercial scale with defined controls.
- 05
Manufacturing
Production of pellets, MUPS, granules and finished dosage forms.
- 06
Quality release
Products released only after analysis by the quality-control laboratory.
- 07
Regulatory support
CTD-format dossier and DMF support per specific country requirements.
- 08
Delivery
Commercial supply for domestic and international business partners.
Product portfolio
Find the right starting point.
Explore our listed portfolio by ingredient, dosage form, strength and release profile.
122 listed formulations
Our divisions
Complementary pharmaceutical expertise.
Let's work together
Your next formulation starts
with a conversation.
Tell us your active ingredient, release profile and target market. Our team can help define the next step.